Bellahcène, Akeila

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.

Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics

Bone health and treatmentsAngiogenesis and VEGF in Cancer

Cited by 854

Methylglyoxal-derived stress: An emerging biological factor involved in the onset and progression of cancer

Bellahcène, A., Nokin, M.-J., Castronovo, V., & Schalkwijk, C. (2018) · Seminars in Cancer Biology

Advanced Glycation End Products researchCancer, Hypoxia, and Metabolism

Cited by 98

Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., Koopmansch, B., MacKay, G. M., Chiavarina, B., Costanza, B., et al. (2020) · Cell Reports

Colorectal Cancer Treatments and StudiesPI3K/AKT/mTOR signaling in cancer

Cited by 38